Infectious Disease and Immunology

01Purpose and scope

• This manual supports the course Infectious Disease and Immunology. It is written for clinicians, laboratory staff, infection prevention practitioners, public health workers and students who need to understand how the field is applied day to day, not only what the textbook definitions say. It describes the main activities, decisions, deliverables and stakeholders in this area, along with the tools and standards that shape routine practice.
• The scope covers how a pathogen is identified, how the host response is evaluated, how infections are prevented and controlled, and how immunity is assessed and supported through vaccination and related measures. It does not teach the full biology of every organism or immune pathway, and it does not set treatment protocols for individual patients. Local formularies, hospital policies, national immunization schedules and laboratory validation records always take precedence over general guidance here.

02Core principles

• The first principle is that an infection is a relationship between a pathogen, a host and an environment. Two patients with the same organism may present very differently because of age, underlying conditions, immune status, prior exposure, medications and the route of transmission. Practitioners who reduce the problem to a single organism name tend to miss the factors that change the plan.
• The second principle is that immunity is specific, time dependent and measurable only in limited ways. Antibody levels, cell mediated responses and documented vaccination history each give partial information. A positive antibody result does not always mean protection, and a negative result does not always mean susceptibility. Interpretation depends on the assay, the reference range supplied by the laboratory and the clinical question being asked.
• The third principle is that transmission routes determine control measures. Droplet, airborne, contact and vehicle transmission each call for different barriers, room handling, cleaning and staff behavior. Matching the precaution to the most likely route is more useful than applying the strictest precaution to everything.

03Planning and preparation

• Before any assessment, investigation or intervention, clarify the question. A clinician may need to decide whether empiric coverage is needed while cultures are pending. An infection preventionist may need to decide whether a cluster on a ward is more than coincidence. A laboratory may need to decide which test panel answers a specific diagnostic question without generating results that nobody can act on. Writing the question in one sentence before starting prevents much wasted effort.
• Preparation also means knowing the local resources. Identify the microbiology laboratory's specimen requirements, turnaround times and reporting contacts. Confirm who is authorized to approve isolation orders, outbreak investigations, vaccine storage and use of off label products. Know the mandatory notifiable disease list for your jurisdiction and where the current version is published, because these lists change and differ between countries and between states or provinces within a country.

04Recommended workflow

1. 1
   : Define the clinical or public health question and record the patient, unit or population involved, along with the time frame and the source of the concern.
2. 2
   : Collect a complete history covering symptoms and onset, exposures, travel, animal contact, food and water sources, medications, prior infections, vaccination status and known immune conditions. Note what is missing so it can be obtained later.
3. 3
   : Select specimens and tests that fit the likely pathogen and the clinical stage. Collect them before antimicrobial therapy when that is clinically safe and feasible, label them completely and send them with the requisition details the laboratory needs for interpretation.
4. 4
   : Interpret results in context. Review culture growth, antigen or nucleic acid results, serology pairs and susceptibility reports together rather than in isolation. Ask the laboratory about known limitations, such as cross reactivity, timing of antibody response or contamination risk.
5. 5
   : Decide on the action and record the reasoning. This may be a treatment choice, an isolation order, a contact tracing request, a vaccination recommendation or a reportable disease notification. Name the person responsible and the expected follow up date.
6. 6
   : Communicate the result and plan to the people who need it, using plain language and clear instructions. Confirm that the receiving person has understood what changes for them.
7. 7
   : Review the outcome at the agreed point, close the loop with the laboratory and the notifying authority where required, and update the record with the final classification or disposition.

05Quality checks, risk controls and compliance

• Quality in this field rests on specimen integrity, analytical validation and clear reporting. Check that specimens are collected in the correct container, transported within the stability window and accepted by the laboratory. Confirm that controls run with each batch and that the laboratory's internal quality program is current. Results from a laboratory without documented validation for a given assay should be treated with caution until the gap is understood.
• Risk controls include standard precautions for all patients, additional transmission based precautions when indicated, safe handling of sharps and biological waste, and appropriate biosafety containment for laboratory work. The Biosafety in Microbiological and Biomedical Laboratories guidance from the US Centers for Disease Control and Prevention and the National Institutes of Health is widely used as a reference for laboratory containment levels, and the Centers for Disease Control and Prevention and the World Health Organization publish widely used infection prevention guidance. Confirm which document your employer and regulator actually require.
• This guidance does not replace qualified professional judgment, approved procedures or required authorization. Reporting obligations, immunization requirements, specimen handling rules and occupational health obligations depend on jurisdiction and employer policy, so check the current authoritative source for your location before acting.

06Collaboration and documentation

• Infection work involves many roles. Clinicians, nurses, pharmacists, microbiologists, infection prevention staff, occupational health teams, environmental services and public health officers each hold part of the picture. A standing contact list, agreed escalation paths and a shared case or outbreak log reduce delays. Hold brief case reviews when a result changes management, and record who attended and what was decided.
• Documentation should allow another competent person to understand the case without asking the original author. Record the question, the evidence used, the decision, the rationale, the person accountable and the review date. Keep antimicrobial stewardship notes, isolation decisions and vaccine administration details in the locations your system requires. Avoid vague entries such as probable infection without stating the criteria used.

07Measures and continuous improvement

• Useful indicators in this area include the proportion of cultures collected before antimicrobial start where feasible, the rate of specimen rejection by the laboratory, time from result to documented action, completeness of isolation documentation, and vaccination coverage within a defined population. Each indicator needs a clear definition, a data source and an owner. Indicators based on small numbers can swing widely, so trends over several periods matter more than single values.
• Continuous improvement works best when it begins with a specific failure. Review a sample of cases where the action was late or the specimen was unsuitable, identify the step where the process broke down and test one change at a time. Share findings with the teams involved. Be cautious about setting numerical targets without a local baseline, because targets copied from other settings may not reflect your patient mix or laboratory capacity.

08Common mistakes and how to prevent them

• A frequent mistake is treating a laboratory result as a diagnosis on its own. A positive test may reflect colonization, contamination or a past infection. Prevent this by reviewing the result against the clinical picture and asking the laboratory whether the finding is likely to be significant for this specimen type.
• Another common error is applying isolation or vaccination decisions from memory after guidance has changed. Build a habit of checking the current local policy or national publication before making a decision that affects other people. A third error is incomplete specimen labeling or missing exposure history, which can make an accurate result impossible to interpret. A short pre collection checklist at the bedside or in the clinic prevents many of these problems.

09Practical checklist

• Write the clinical or public health question in one sentence before ordering tests or acting.
• Confirm specimen type, container, labeling and transport requirements with the receiving laboratory.
• Record exposure, travel, animal contact, medication and vaccination history alongside the test request.
• Interpret each result with the clinical picture and the laboratory's stated limitations.
• Document the decision, the reasoning, the accountable person and the review date.
• Check current national, state or local reporting and isolation requirements before acting.
• Close the loop with the laboratory, the patient or unit and any notifying authority.
• Review a sample of cases each period and record one change to test.

★Learning sources

• Micro Degree: Infectious Disease and Immunology
• Micro Degree: Healthcare Administration Practice
• Micro Degree: Physiotherapy Assistant Operations
• Micro Degree: Cardiac Care Support